These 5 Cytomegalovirus (CMV) peptides, at 0.25 mg each (total of 1.25 mg/vial), constitute part of the CEF control peptide pool . Now available separately as CMV control peptide pool, Influenza control peptide pool  and EBV control peptide pool , these peptides have been used in the stimulation of IFNgamma release from CD8+ T cells in individuals with defined HLA types, these epitopes are useful in applications such as ELISPOT, intracellular cytokine and CTL assays. All peptides are provided as net weight based on peptide content.